anonymous
Guest
anonymous
Guest
GlaxoSmithKline, which holds about a two-thirds share in the Consumer Healthcare business JV with its partner Novartis, plans to acquire the rest of the 36.5% stake held by Novartis for $13 billion. https://news.alphastreet.com/glaxo-buys-novartis-share-of-consumer-healthcare-joint-venture/